Status:
SUSPENDED
The Use of Ventriject to Assess V02Max in Patients Admitted to Hospital in the Emergency Surgery Setting
Lead Sponsor:
The Leeds Teaching Hospitals NHS Trust
Conditions:
Emergencies
Surgery
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to assess whether Ventriject V02Max can provide values in a clinical setting and whether this value correlates with clinical outcome in patients admitted to the emergency gene...
Detailed Description
Pre-operative risk stratification is an important aspect of clinical decision-making in patients undergoing surgery. Thorough pre-operative assessment aids in the evaluation of mortality and morbidity...
Eligibility Criteria
Inclusion
- Adults (\>18 years of age)
- Admitted under the General Surgery team within the last 24- 48 hours
- Anticipated hospital stay of a minimum of 48 hours
Exclusion
- Patients who are unable to consent for participation in the study for any reason.
Key Trial Info
Start Date :
November 3 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 11 2025
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT06189131
Start Date
November 3 2023
End Date
November 11 2025
Last Update
March 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Leeds Teaching Hospitals NHS Trust
Leeds, United Kingdom